Seguir
Varun Monga
Varun Monga
Dirección de correo verificada de uiowa.edu - Página principal
Título
Citado por
Citado por
Año
O2⋅− and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate
JD Schoenfeld, ZA Sibenaller, KA Mapuskar, BA Wagner, ...
Cancer cell 31 (4), 487-500. e8, 2017
4202017
Radioresistance in Glioblastoma and the Development of Radiosensitizers
MY Ali, CR Oliva, ASM Noman, BG Allen, PC Goswami, Y Zakharia, ...
Cancers 12 (9), 2511, 2020
942020
Improved survival for extremity soft tissue sarcoma treated in high‐volume facilities
T Abarca, Y Gao, V Monga, MR Tanas, MM Milhem, BJ Miller
Journal of surgical oncology 117 (7), 1479-1486, 2018
662018
First-in-human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma
BG Allen, KL Bodeker, MC Smith, V Monga, S Sandhu, R Hohl, T Carlisle, ...
Clinical cancer research 25 (22), 6590-6597, 2019
552019
Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models
JD Schoenfeld, ZA Sibenaller, KA Mapuskar, MD Bradley, BA Wagner, ...
Redox biology 14, 417-422, 2018
542018
Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations
PK Brastianos, EL Twohy, ER Gerstner, TJ Kaufmann, AJ Iafrate, ...
Journal of clinical oncology 41 (3), 618-628, 2023
44*2023
Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and …
G Bathla, S Priya, Y Liu, C Ward, NH Le, N Soni, RP Maheshwarappa, ...
European radiology 31 (11), 8703-8713, 2021
382021
A retrospective analysis of the efficacy of immunotherapy in metastatic soft-tissue sarcomas
V Monga, KM Skubitz, S Maliske, SL Mott, H Dietz, AC Hirbe, BA Van Tine, ...
Cancers 12 (7), 1873, 2020
382020
CDKs in sarcoma: mediators of disease and emerging therapeutic targets
JL Kohlmeyer, DJ Gordon, MR Tanas, V Monga, RD Dodd, DE Quelle
International journal of molecular sciences 21 (8), 3018, 2020
382020
Ipilimumab: from preclinical development to future clinical perspectives in melanoma
P Letendre, V Monga, M Milhem, Y Zakharia
Future Oncology 13 (7), 625-636, 2017
362017
Mitochondrial superoxide increases age-associated susceptibility of human dermal fibroblasts to radiation and chemotherapy
KA Mapuskar, KH Flippo, JD Schoenfeld, DP Riley, S Strack, TA Hejleh, ...
Cancer research 77 (18), 5054-5067, 2017
352017
Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics
S Priya, Y Liu, C Ward, NH Le, N Soni, R Pillenahalli Maheshwarappa, ...
Scientific reports 11 (1), 10478, 2021
322021
Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
Y Zakharia, V Monga, U Swami, AD Bossler, M Freesmeier, M Frees, ...
Oncotarget 8 (51), 89182, 2017
322017
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
MI de la Fuente, H Colman, M Rosenthal, BA Van Tine, D Levacic, ...
Neuro-oncology 25 (1), 146-156, 2023
312023
Radiology gets chatty: the ChatGPT saga unfolds
H Grewal, G Dhillon, V Monga, P Sharma, VS Buddhavarapu, G Sidhu, ...
Cureus 15 (6), 2023
302023
Non-conventional treatments for conventional chondrosarcoma
V Monga, H Mani, A Hirbe, M Milhem
Cancers 12 (7), 1962, 2020
282020
Turning ‘Cold’tumors ‘Hot’: immunotherapies in sarcoma
J Rytlewski, MM Milhem, V Monga
Annals of translational medicine 9 (12), 2021
262021
Survival after reoperation for recurrent glioblastoma
RW Woodroffe, M Zanaty, N Soni, SL Mott, LC Helland, A Pasha, J Maley, ...
Journal of clinical neuroscience 73, 118-124, 2020
222020
A phase Ib/II study of olutasidenib in patients with relapsed/refractory IDH1 mutant gliomas: Safety and efficacy as single agent and in combination with azacitidine.
MI De La Fuente, H Colman, M Rosenthal, BA Van Tine, D Levaci, ...
Journal of clinical oncology 38 (15_suppl), 2505-2505, 2020
212020
Financial impact of oral chemotherapy wastage on society and the patient
V Monga, C Meyer, B Vakiner, G Clamon
Journal of oncology pharmacy practice 25 (4), 824-830, 2019
202019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20